LOGIN
Higher cost & lack of analgesia benefit with liposomal bupivacaine vs bupivacaine/morphine
January 2017
Higher cost & lack of analgesia benefit with liposomal bupivacaine vs bupivacaine/morphine
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
The AAHKS Clinical Research Award: Liposomal Bupivacaine and Periarticular Injection Are Not Superior to Single-Shot Intra-articular Injection for Pain Control in Total Knee Arthroplasty
J Arthroplasty. 2016 Sep;31(9 Suppl):22-5Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
207 patients scheduled for total knee arthroplasty were randomized to postoperative analgesia with either periarticular liposomal bupivacaine, periarticular bupivacaine and morphine, or intraarticular bupivacaine and morphine. Patients were assessed postoperatively for mean pain during the hospital stay, maximum pain during the hospital stay, and mean morphine equivalents taken per 24 hours. The c...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.